2 recruiting, 1 active not recruiting, 1 withdrawn. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 3 | Recruiting 2, Active not recruiting 1 |
Follow Low-dose Radiotherapy: new trials by email Literature Review of Low-dose Radiotherapy trials Research Report on Low-dose Radiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study Low-dose Radiotherapy, Pucotenlimab, AG regimen - Pancreatic Cancer, PD-L1 | Phase 1 / Phase 2 | Recruiting | Zhejiang Provincial People's Hospital | 10 | 2025-09-30 | 2026-01-26 |
| Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC Low-dose radiotherapy, Tifcemalimab injection, Toripalimab - Extensive-stage Small-cell Lung Cancer | Phase 1 | Withdrawn | Sichuan University | 2025-01-10 | 2026-04-29 | |
| Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC AK104, Etoposide, Carboplatin - SCLC, Extensive Stage | Phase 1 / Phase 2 | Active not recruiting | Sichuan University | 57 | 2024-05-16 | 2026-04-29 |
| Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC Low-dose radiotherapy, Etoposide, Cisplatin - Lung Cancer, Extensive-stage Small-cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Sichuan University | 45 | 2024-04-18 | 2026-05-05 |
Small Cell Lung Carcinoma (2) · Lung Neoplasms (1) · Pancreatic Neoplasms (1)
Sichuan University (3) · Zhejiang Provincial People's Hospital (1)
China (3)
You Lu, MD (1)